Validation of Residual Proliferative Cancer Burden as a...

  • Main
  • 2020 / 07
  • Validation of Residual Proliferative Cancer Burden as a...
The Oncologist 2020 / 07

Validation of Residual Proliferative Cancer Burden as a Predictor of Long‐Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor–Positive/Human Epidermal Growth Receptor 2–Negative Breast Cancer

Miglietta, Federica, Dieci, Maria Vittoria, Tsvetkova, Vassilena, Griguolo, Gaia, Vernaci, Grazia, Menichetti, Alice, Faggioni, Giovanni, Giarratano, Tommaso, Mioranza, Eleonora, Genovesi, Elisa, Cume
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2020-0201
Date:
July, 2020
File:
PDF, 2.17 MB
2020
Conversion to is in progress
Conversion to is failed